Price T Rowe Associates Inc Legend Biotech Corp Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 6,808,081 shares of LEGN stock, worth $239 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,808,081
Previous 11,165,584
39.03%
Holding current value
$239 Million
Previous $544 Million
59.28%
% of portfolio
0.03%
Previous 0.06%
Shares
14 transactions
Others Institutions Holding LEGN
# of Institutions
232Shares Held
84MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$263 Million3.96% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$210 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$201 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$200 Million0.86% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.5MShares$123 Million4.74% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.87B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...